CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 8,246 shares at $1.31 ($10,802)
- 4 Open-market sale President and CEO sold 13,853 shares at $1.30 ($18,009)
- 4 Grant or award Chief Financial Officer acquired 34,200 shares (grant or award)
- 4 Grant or award S.V.P., General Counsel acquired 34,200 shares (grant or award)
- 4 Grant or award President and CEO acquired 56,700 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 1,000,000 shares at $1.70 ($1,700,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Pres & CEO acquired 125,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award S.V.P., General Counsel acquired 75,000 shares (grant or award)
Page 13 of 23 · 459 filings